GENEVA, July 27 -- EXCIVA GMBH filed a patent application (US2026/011273) for “COMPOSITIONS AND METHODS FOR MODULATING PLASMA LEVELS OF BRAIN-DERIVED NEUROTROPHIC FACTOR”. With publication no. WO/2026/156077, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61K 31/485
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....